Georgios Kementzidis

This study uses molecular dynamics simulations to analyze structural changes in eIF4E when bound to Cap and in its apo form, identifying key residues involved in conformational transitions and suggesting targets for drug design.

This paper develops an AI framework to generate and optimize BACE1 inhibitors for Alzheimer's disease, identifying 14 candidates with improved binding properties.